Lewes, DE -- (SBWire) -- 03/18/2016 --The Chinese medical device market is set to rise from $27.7 billion in 2014 to an estimated $50.8 billion by 2020, expanding at a strong Compound Annual Growth Rate (CAGR) of 10.6%. This substantial increase will be driven by a number of factors, including the increasing prevalence of metabolic syndromes and chronic diseases, an aging population, as well as government investment. These factors are all linked, as an aging population will lead to increased incidences of chronic diseases such as respiratory diseases, cancers and cardiovascular disease. This will provide medical device manufacturers with opportunities for growth. The leading device companies in China who will benefit are Siemens Healthcare, GE Healthcare, Philips Healthcare, Medtronic and Roche. The dominant player in terms of revenue in China is Siemens, which has a best-in-class portfolio of ultrasound and medical imaging solutions.
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China report provides analysis of the healthcare, regulatory, and reimbursement landscape in China, including an overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
For more information Visit at: http://www.marketresearchreports.com/globaldata/countryfocus-healthcare-regulatory-and-reimbursement-landscape-china
Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare
About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.
Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions
